Regeneron Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. (REGN) slid 2.55% to $623.05 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.57% to 4,123.34 and Dow Jones Industrial Average falling 0.30% to 32,899.37. This was the stock's second consecutive day of losses. Regeneron Pharmaceuticals Inc. closed $124.37 short of its 52-week high ($747.42), which the company achieved on April 8th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson (JNJ) fell 0.22% to $176.37, Novartis AG ADR (NOVN.EB) fell 0.45% to $85.82, and Amgen Inc. (AMGN) rose 0.92% to $236.50. Trading volume (767,703) eclipsed its 50-day average volume of 643,281.
Data source: Dow Jones Market Data, FactSet. Data compiled May 6, 2022.
(END) Dow Jones Newswires
May 06, 2022 17:18 ET (21:18 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.